drugset / Trial / NCT00883194
A Safety and Effectiveness Pilot Study of PRF-108 and PRF-110 in Healthy Volunteers
RandomizedSingle-groupQuadruple-blindTreatment
Summary
This is a clinical study testing PRF-108 and PRF-110 (a new extended release 4% gel formulations of ropivacaine) in an experimentally induced pain model in healthy volunteers. PRF-108 and PRF-110 are designed to deliver slow release of ropivacaine over 72 hours.
Timeline
- Start
- 2010-10
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PRF-108 | Unknown | 4 % | — |
| Subject | Ropivacaine | Other / unclassified | 0.5 % | — |
| Subject | Ropivacaine | Other / unclassified | 4 % | — |
Indications
No indication recorded.